Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |